Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM) — Stella

Home/Diabetes Mellitus, Type 2/

View on ClinicalTrials.gov

Recruiting

Back to Diabetes Mellitus, Type 2 trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven, Connecticut

Key details

Sponsor

Yale University

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~24 participants

Started

July 2024

Primary completion

May 2027

Age range

18 Years – 60 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.